The current results support this approach. "It is known that inhibiting NLRP3 not only reduces neuroinflammation, but also helps microglia clear the harmful amyloid-beta deposits, a process called ...

New research reveals key differences in how the brain's immune system responds to the disease compared to a bacterial ...

A growing body of research suggests that infections, including those caused by common bacteria in gum disease, could ...

A Massachusetts man became the first person to try intranasal foralumab under an expanded access program for people with ...

Reports Q2 revenue $1.11M vs $1.24M last year. Eric A. Adams, InMed’s Chief Executive Officer, commented, “We are pleased with the steady ...

"It is known that inhibiting NLRP3 not only reduces neuroinflammation, but also helps microglia clear the harmful amyloid-beta deposits, a process called phagocytosis. The novelty of our findings ...

The ‘NLRP3 inflammasome’ is like a control switch. In Alzheimer’s disease, its activation triggers an inflammatory response ...